1 / 4

Hematology Market Analysis and Forecast Model (COVID-19 Market Impact)

Hematology is a branch of medical science concerned with diagnosis, treatment and study of blood and disorders related to blood.

5186
Download Presentation

Hematology Market Analysis and Forecast Model (COVID-19 Market Impact)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hematology Market Analysis and Forecast Model Hematology Market Analysis and Forecast Model (COVID-19 Market Impact) (COVID-19 Market Impact) Hematology is a branch of medical science concerned with diagnosis, treatment and study of blood and disorders related to blood. It includes the treatment of blood disorders such as leukemia, malignancies and types of hemophilia, sickle-cell anemia and lymphoma. There are four major areas of study within hematology which include hematological malignancies, hemoglobinopathy, coagulopathy, and anemia. The global hematology market size is valued at US$ 4537.5 million in 2019, and is expected to exhibit a CAGR of 7.80% over the forecast period (2019–2027). Request Sample Copy of the Business Report: Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/943 https://www.coherentmarketinsights.com/insight/request-sample/943 Increasing incidence of blood related disorders is expected to propel the growth of the global Increasing incidence of blood related disorders is expected to propel the growth of the global hematology market hematology market Rising incidence of blood cancer is a major factor contributing to growth of the market. For instance, according to GLOBOCAN 2018, more than 1.85 million new blood cancer cases are expected to be diagnosed in 2040 across the globe. Furthermore, according to the American Cancer Society, Non Hodgkin lymphoma is one of the more common types of cancer in the U.S., accounting for 4% of all cancer cases. An estimated 74,680 patients were diagnosed with Non Hodgkin lymphoma in the U.S. in 2018. Moreover, increasing incidence of hemophilia and sickle-cell anemia is expected to drive growth of the global hematology market. For instance, according to the World Federation of Hemophilia’s (WFH) 2018 statistics, around 440,000 people had hemophilia, out of which around 173,000 people were diagnosed with hemophilia A or B in 2017 globally. Furthermore, as per the World Health Organization, in 2018, the prevalence of anemia in children was around 45%, and 12% in men, and it is increasing rapidly all over the world.

  2. Similarly, According to the National Institute of Health (NIH), anemia affects 30% of women in the reproductive age and 40% of pregnant women, globally. Stringent regulatory and reimbursement policies on product launches, as well as product recalls due to safety violation are projected to hamper growth of the market over the forecast period. For instance, in April 2017, Sysmex, a Japanese medical devices company recalled 3,682 XN Series Automated Hematology Analyzers, owing to increases in incidences of fire caused due to improper alignment of an internal protective sheet that protects electronic components from salty reagents used in hematological sample analysis Increasing number of product launches is expected to propel the market growth over the Increasing number of product launches is expected to propel the market growth over the forecast period forecast period New product launches by key players operating in global market are expected to propel growth of the global hematology market. For instance, in May 2018, Beckman Coulter, a Danaher Corporation company that develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing, launched the DxH 900 hematology analyzer which performs complete blood count and white blood cell differential tests with minimal repeats for application in mid-to high-volume clinical laboratories. In February 2018, Horiba, a Japanese manufacturer of precision instruments for measurement and analysis, launched Yumizen G range of semi-automatic to fully automatic hemostasis solutions for clinical testing. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Hematology Market Research Objective and Assumption • Hematology Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Hematology Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Hematology Market, By Regions • Hematology Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Hematology Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors.

  3. • Hematology Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Hematology Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Apply Promo Code "CMIFIRST1000" And Get Instant Discount Of USD 1000 Apply Promo Code "CMIFIRST1000" And Get Instant Discount Of USD 1000 Buy Now This Premium Report to Grow your Business @ Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/943 https://www.coherentmarketinsights.com/insight/buy-now/943 Moreover, increasing adoption of certifications for quality enhancement by key players operating in the global hematology market is expected to propel the market growth over the forecast period. In November 2017, Sysmex received CLIA Waiver certification under the U.S. regulatory approval system for the XW-100 automated hematology analyzer. It is the latest product in the hematology field targeting the U.S. market. Key Players Key Players Major players operating in the global hematology market include Abbott Laboratories, Sysmex Co., Beckman Coulter, Horiba, Ltd., Boule Diagnostics AB, Mind ray Medical International Limited, Siemens Healthcare, Roche Diagnostics, Bio Rad laboratories, Sigma Aldrich Co., Nihon Kohden Corporation. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive

  4. analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related